Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, has made available for free on their Web site a report that details how key government activities are affecting the biopharmaceutical industry. The report entitled Pharma and the Feds: Key Government Activities and How They Affect the Biopharmaceutical Industry covers enacted and proposed legislation in front of Congress including the Healthcare Information Technology Acts, stem cell research, Medicare Improvements for Patients and Providers Act of 2008 and much more.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081022/NEW021 )

A section in the report entitled "All Eyes on the White House" breaks down the implications for pharma depending on which candidate makes it to office and covers overall political trends relating to the pharma industry like the fact that pharma industry donations to Democratic candidates are outpacing those to Republicans. This deviation (the pharma industry usually aligns with Republicans) can be attributed to John McCain's support of several issues that the pharma industry opposes such as drug importation and biosimilars.

Also available to the media is a detailed figure entitled "Drug Reimportation Timeline: Politics, Patient's Rights, and Pharmaceutical Industry Lobbying." The figure displays major events from October 2001 through November 2008 that are affecting drug reimportation. The figure is included in this release, and media may contact Decision Resources for a higher resolution if needed.

About Spectrum

Pharma and the Feds: Key Government Activities and How They Affect the Biopharmaceutical Industry is a special report from Spectrum, an executive advisory service that identifies and analyzes key business and technology drivers of the pharmaceutical and biotechnology markets. Available only through Decision Resources, Spectrum is a mix of publications and telephone inquiry access to analysts that provides an "over the horizon" perspective on complex healthcare issues.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Natalia Morales                           Elizabeth Marshall   Decision Resources                        Decision Resources, Inc.   781-296-2691                              781-296-2563   nmorales@dresources.com                   emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20081022/NEW021
AP Archive: http://photoarchive.ap.org/
AP PhotoExpress Network: PRN1
PRN Photo Desk, photodesk@prnewswire.com

SOURCE: Decision Resources

CONTACT: Natalia Morales of Decision Resources, +1-781-296-2691,
nmorales@dresources.com, or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Health Plan of Nevada Medicare Advantage Plan Offers Value-Based Drug Option

View Now